Abstract:Abstract Introduction Progressive hypercarbic respiratory failure in the absence of overt intrinsic lung disease, thoracic cage abnormalities, CNS depressants, or neuromuscular disease poses a unique diagnostic challenge. Furthermore, continued respiratory failure in patients compliant with non-invasive ventilation warrants additional evaluation for alternative diagnoses. We present a case which produced a unique diagnostic challenge to the inpatient sleep medicine service. Report of case(s) A 46 year-old female with a past medical history significant for T2DM, COVID pneumonia, and seizures presented for acute on chronic hypercarbic respiratory failure in the setting of left hemi-diaphragm paralysis. She experienced multiple (greater than ten) hospitalizations requiring intubation for hypercarbic respiratory failure. Initial work up revealed negative inspiratory force of -40 cm H20. Pulmonary function tests revealed a restrictive pattern with FEV1/FVC of 70%. CT Chest revealed no parenchymal abnormalities. Admission ABG of 7.30/56. She was started on non-invasive ventilation through average volume assured pressure support mode with goal volumes of eight cc/kg. Despite effective ventilatory support with excellent compliance she had increasing requirements leading to near twenty-four hours of total use. Repeat hospitalization occurred for respiratory failure and new left arm weakness which raised concern for underlying neuromuscular disease as etiology. MuSK antibodies were sent and resulted positive at a titer of 1.35nmol/L, consistent with a diagnosis of Myasthenia gravis. The patient was treated with prednisone, plasma exchange, and rituximab with marked improvement in clinical and respiratory status. The patient was successfully weaned down to nocturnal use of non-invasive ventilation with preserved eucarbia. Conclusion Myasthenia gravis can lead to marked respiratory muscle weakness and respiratory failure. Common triggers of crisis include infection, medications, electrolyte abnormalities, and thyroid disease. Up to twenty percent of patients present with myasthenic crisis as their initial symptoms. Continued evaluation of forced vital capacity, and negative inspiratory force are important measures to follow for signs of disease progression. This case proved difficult in the setting of recurrent admissions believed to be secondary to hemidiaphragm paralysis and previous COVID infection. It is imperative to maintain a broad differential in working up respiratory failure and consider myasthenia in the proper clinical context. Support (if any)

Respiratory failure as the presenting manifestation of adult-onset mitochondrial myopathy: 1 case report with literature review

Acute Respiratory Failure is the Initial Manifestation in the Adult-Onset A3243G Trnaleu Mtdna Mutation: A Case Report and the Literature Review

Pulmonary Benign Metastasizing Leiomyoma Presented As Acute Hypoxemic Respiratory Failure: A Case Report

Acute Mitochondrial Myopathy with Respiratory Insufficiency and Motor Axonal Polyneuropathy.

Pulmonary Hypertension As a Manifestation of Mitochondrial Disease

Weaning Difficulty after Severe Pneumonia in Adult-Onset Mitochondrial Myopathy with A3243G Mutation in the Mitochondrial Trna Gene: A Case Report

Hereditary myopathy with early respiratory failure in China: one case report and literatures review

Treatment of a Patient with Severe Lactic Acidosis and Multiple Organ Failure Due to Mitochondrial Myopathy: A Case Report.

A Case Report of Myotonic Dystrophy Type 1 Presenting as Acute Respiratory Failure

Respiratory failure as first presentation of myasthenia gravis: a case report

Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation – a case report

1217 A Complex Case of Progressive Hypercarbic Respiratory Failure

Mitochondrial Myopathy in a 21-Year-Old Man Presenting With Bilateral Lower Extremity Weakness and Swelling

Clinical Profile and Outcome of Pediatric Mitochondrial Myopathy in China

Reversible cardiac function and left ventricular hypertrophy in a Chinese man with mitochondrial myopathy: a case report

Respiratory Failure As the Prominent Manifestation of Entecavir-Associated Mitochondrial Myopathy: a Case Report.

Mitochondrial Dysfunction as a Pathogenic Mediator of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis

Unusual cause of muscle weakness, type II respiratory failure and pulmonary hypertension: a case report of ryanodine receptor type 1(RYR1)-related myopathy

Decreased Muscle Strength, Type 2 Respiratory Failure, Heart Failure, Positive Anti-mitochondrial Antibodies—Rare Atypical Manifestations of Inflammatory Myopathy

Comparison of the stage-dependent mitochondrial changes in response to pressure overload between the diseased right and left ventricle in the rat

Mitochondrial Dysfunction in Chronic Respiratory Diseases: Implications for the Pathogenesis and Potential Therapeutics